Combination of valproic acid and morpholino splice-switching oligonucleotide produces improved outcomes in spinal muscular atrophy patient-derived fibroblasts
This study provides the first indication of a novel dual therapy approach for the potential treatment of SMA. Graphical abstract
Source: Neurochemistry International - Category: Neuroscience Source Type: research
More News: Brain | Chemistry | Genetics | Motor Neurone Disease | Neurology | Neuroscience | Spinal Muscular Atrophy | Study